Results
93
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
93 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
300031 | CN¥16.65 | 15.2% | -8.2% | CN¥6.9b | CN¥17.52 | PE39.6x | E30.6% | 0.4% | ||
TOURN | SEK 9.06 | 13.0% | 24.1% | SEK 88.4m | SEK 13.00 | PB3.5x | E103.8% | n/a | ||
ILLM | CA$1.74 | 1.8% | -4.4% | CA$88.2m | CA$2.65 | PB1.2x | E114.8% | n/a | ||
NITRO | SEK 2.08 | -7.1% | -24.9% | SEK 51.8m | SEK 8.99 | PB2.2x | E108.0% | n/a | ||
ZDGE | US$3.42 | 7.5% | 56.2% | US$49.5m | US$7.00 | PS1.7x | E103.2% | n/a | ||
300251 | CN¥7.87 | 18.2% | -8.5% | CN¥22.9b | CN¥8.87 | PE33.3x | E25.0% | 0.9% | ||
7844 | JP¥603.00 | 2.7% | -15.4% | JP¥36.5b | n/a | PS1.3x | E67.5% | 5.5% | ||
A035900 | ₩51,000.00 | 14.2% | -54.6% | ₩1.7t | ₩70,782.61 | PE23.6x | E22.6% | 1.1% | ||
ALBLD | €14.45 | -0.3% | -4.3% | €65.7m | €21.43 | PE23.4x | E30.5% | n/a | ||
M8G | €3.60 | 2.9% | 233.3% | €670.9m | €4.49 | PE13.1x | E20.1% | n/a | ||
PVRINOX | ₹1,684.70 | 1.8% | -1.9% | ₹165.3b | ₹1,739.82 | PS2.8x | E60.4% | 0% | ||
ATUS | US$2.50 | 14.2% | -23.5% | US$1.6b | US$2.61 | PE-28.4x | E36.8% | n/a | ||
SSTK | US$35.53 | 0.6% | -6.6% | US$1.3b | US$53.25 | PE26.7x | E29.6% | 3.4% | ||
SEAT | US$3.59 | -2.7% | -44.1% | US$747.0m | US$7.40 | PE12.9x | E20.3% | n/a | ||
7069 | JP¥1,052.00 | -4.4% | -43.2% | JP¥4.2b | n/a | PB13.4x | E47.8% | n/a | ||
A122870 | ₩37,850.00 | 18.3% | -39.7% | ₩702.0b | ₩47,875.00 | PE52.9x | E58.7% | 0.8% | ||
REMEDY | €16.94 | 0.4% | -29.3% | €229.9m | €21.00 | PS5.9x | E67.9% | 0% | ||
CTV | US$1.82 | -1.6% | 42.2% | US$266.5m | US$2.83 | PS1.8x | E101.7% | n/a | ||
PRS | €0.33 | -3.8% | -11.2% | €352.1m | n/a | PE-17.1x | E92.9% | n/a | ||
TBLA | US$3.28 | 0.9% | -13.5% | US$1.1b | US$5.50 | PB1.1x | E59.5% | n/a | ||
2130 | JP¥958.00 | 1.2% | -19.7% | JP¥12.2b | JP¥850.00 | PE68.6x | E37.6% | 3.3% |